Industry Advocacy

Omega-3 fatty acid supplements are consumed by 16% of U.S. adults according to a recent survey by CRN.

DSN contributing editor Ed Rowland offers a dispatch from the 2018 CHPA Annual Executive Conference — from legislative updates to presentations and a new organizational structure.

In addition, current CHPA board member J.P. Borneman, chairman and CEO, Hyland’s, was elected to the CHPA board of director’s executive committee.

John Hendrickson spent most of his career in the OTC business working for a single company over a span of 29 years - private brand manufacturer Perrigo.

A national survey by Morning Consult commissioned by NACDS found 76% of respondents say they support rules that would require all prescriptions being handled electronically.

CRN's new assistant general counsel most recently held the position of special counsel for Wiley Rein in Washington. Prior to that position, she spent more than two years as senior counsel at Walgreens.

According to the Food and Drug Administration, SARMs are unapproved drugs illegally marketed as dietary supplements.

Seventy-eight percent of respondents to a National Community Pharmacists Association survey said that DIR fees hinder their ability to plan for their businesses’ future, with three-quarters saying the fees make their cashflow unpredictable.